272 related articles for article (PubMed ID: 26174366)
1. Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.
Wen S; Zhou W; Li CM; Hu J; Hu XM; Chen P; Shao GL; Guo WH
BMC Cancer; 2015 Jul; 15():520. PubMed ID: 26174366
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Ki-67 in stage I non-small-cell lung cancer: A meta-analysis involving 1931 patients.
Xu J; Liu P; Da J; Hao J; Peng W; Sun G
Pathol Res Pract; 2019 May; 215(5):855-860. PubMed ID: 30871912
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
4. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
6. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis.
He X; Chen Z; Fu T; Jin X; Yu T; Liang Y; Zhao X; Huang L
BMC Cancer; 2014 Mar; 14():153. PubMed ID: 24597851
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell Lung Cancer; Relationship With Ki-67 and PD-L1.
Pezzuto A; Cappuzzo F; D'Arcangelo M; Ciccozzi M; Navarini L; Guerrini S; Ricci A; D'Ascanio M; Carico E
Anticancer Res; 2020 Feb; 40(2):983-990. PubMed ID: 32014943
[TBL] [Abstract][Full Text] [Related]
11. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.
Wei DM; Chen WJ; Meng RM; Zhao N; Zhang XY; Liao DY; Chen G
Respir Res; 2018 Aug; 19(1):150. PubMed ID: 30103737
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.
Ahn HK; Jung M; Ha SY; Lee JI; Park I; Kim YS; Hong J; Sym SJ; Park J; Shin DB; Lee JH; Cho EK
Tumour Biol; 2014 Jun; 35(6):5735-40. PubMed ID: 24737581
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer.
Mehdi SA; Etzell JE; Newman NB; Weidner N; Kohman LJ; Graziano SL
Lung Cancer; 1998 May; 20(2):99-108. PubMed ID: 9711528
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
17. High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer.
Wu J; Zhou J; Yao L; Lang Y; Liang Y; Chen L; Zhang J; Wang F; Wang Y; Chen H; Ma J
Tumour Biol; 2013 Dec; 34(6):3939-44. PubMed ID: 23838802
[TBL] [Abstract][Full Text] [Related]
18. Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis.
Zhang D; Wang J
J Cancer Res Ther; 2020; 16(4):800-803. PubMed ID: 32930121
[TBL] [Abstract][Full Text] [Related]
19. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis.
Wang Y; Lu Y; Li J; Wu Y; Che G
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):855-860. PubMed ID: 31384932
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]